Heart failure/cardiogenic shock is frequently triggered by ischemic coronary events.
Levosimendan was shown to improve hemodynamics compared to other inotropes or IABP.
The recommendation to use levosimendan varies depending on the blood pressure values.
Levosimendan should be used when urinary output is insufficient after diuretics.
Levosimendan should be preferred over adrenergic inotropes in patients with beta-blockers.